The Spine in β-thalassemia syndromes

Axillary lymph node ratio revisited

Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major

Effects of divalproex sodium on hemoglobin level

Clinicovirologic analysis of hepatitis C infection in transfusion-dependent β-thalassemia major children

Brain positron emission tomography in splenectomized adults with β-thalassemia intermedia: Uncovering yet another covert abnormality

Optimal management of β thalassaemia intermedia

Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): A status quo

Optimal management of β thalassaemia intermedia

Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with β-thalassemia intermedia

Age-related complications in treatment-naïve patients with thalassaemia intermedia

Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia

Switching patients from warfarin to dabigatran therapy: To RE-LY or not to rely

Managing unresponsiveness or intolerance to deferasirox therapy: A tale of two doses

Does absolute excess of alpha chains compromise the benefit of splenectomy in patients with thalassemia intermedia?

Carbamazepine-induced thrombocytopenia

Iron and hepatitis C: What can we learn from thalassemia major?

Brain positron emission tomography in splenectomized adults with β-thalassemia intermedia: Uncovering yet another covert abnormality

To the editor

Evaluation of the 5mg-g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia